World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Saengboonmee C, Sorin S, Sangkhamanon S, Chomphoo S, Indramanee S, Seubwai W, Thithuan K, Chiu CF, Okada S, Gingras MC, Wongkham S. γ-aminobutyric acid B2 receptor: A potential therapeutic target for cholangiocarcinoma in patients with diabetes mellitus. World J Gastroenterol 2023; 29(28): 4416-4432 [PMID: 37576707 DOI: 10.3748/wjg.v29.i28.4416]
URL:	https://www.wjgnet.com/1007-9327/full/v29/i28/4416.htm

(0) (0) (0) (1) (5889) (11)

Number	Citing Articles
1	Ronnakrit Trakoonsenathong, Ching-Feng Chiu, Charupong Saengboonmee. Glucagon-like peptide 1 receptor agonist: A potential game changer for cholangiocarcinoma. World Journal of Gastroenterology 2024; 30(34): 3862-3867 doi: 10.3748/wjg.v30.i34.3862 Abstract(588) \| Core Tip(773) \| Full Article(HTML)(2653) \| Full Article with Cover (PDF)-599K(161) \| Audio-475K(50) \| Peer-Review Report-176K(131) \| Answering Reviewers-89K(124) \| Full Article (PDF)-378K(197) \| Full Article (XML)-80K(148) \| Times Cited (0) \| Total Visits (7846) \| Open
2	A. F. Al-Azzawie, M. A. Ajeel, A. A. H. Al-Bayti. Impact of gamma-aminobutyric acid receptors modulators on renal and liver functional, molecular and histological characteristics in white male mice. Reports of Morphology 2024; 30(4): 82 doi: 10.31393/morphology-journal-2024-30(4)-10
3	Mohammad Amin Elahi Najafi, Masato Yasui, Yuki Teramoto, Tomoyuki Tatenuma, Guiyang Jiang, Hiroshi Miyamoto. GABBR2 as a Downstream Effector of the Androgen Receptor Induces Cisplatin Resistance in Bladder Cancer. International Journal of Molecular Sciences 2023; 24(18): 13733 doi: 10.3390/ijms241813733
4	Atipat Singkarin, Charat Kusoltech, Jirayu Sriphaiboon, Chatchai Phoomak, Charupong Saengboonmee. Glucose addiction of cholangiocarcinoma: opportunities for therapeutic development. Hepatoma Research 2025; doi: 10.20517/2394-5079.2024.128
5	Xueyang Yang, Qianhe Zu, Luxuan Wang, Chunhui Li, Lijian Zhang. The double role of GABAergic system in systemic tumors: an updated review. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1570380
6	Zhao Liu, Shanshan Yu, Xinyan Jin, Luguang Sheng, Mai Re YanMu, Jie Gao, Jun Lu, Tao Lei. The Clinical Application of GLP-1RAs and GLP-1/GIP Dual Receptor Agonists Based on Pharmacological Mechanisms: A Review. Drug Design, Development and Therapy 2025; : 10383 doi: 10.2147/DDDT.S559919
7	Ronnakrit Trakoonsenathong, Waritta Kunprom, Chaiwat Aphivatanasiri, Padcharee Yueangchantuek, Paslada Pimkeeree, Supannika Sorin, Kullanat Khawkhiaw, Ching-Feng Chiu, Seiji Okada, Sopit Wongkham, Charupong Saengboonmee. Liraglutide exhibits potential anti-tumor effects on the progression of intrahepatic cholangiocarcinoma, in vitro and in vivo. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-64774-2
8	Qiongfang Zhang, MengJie Xia, Dan Gui, Jia Wei, Yongfeng Liu, Yanhua Gou. Case report of stiff - person syndrome and literature review. IBRO Neuroscience Reports 2026; 20: 112 doi: 10.1016/j.ibneur.2025.12.006
9	Kullanat Khawkhiaw, Worachart Lert-Itthiporn, Naisana Seyedasli, Ching-Feng Chiu, Charupong Saengboonmee. Reprogramming of amino acid metabolism in cholangiocarcinoma: A potential target for metabolic-targeted therapy. World Journal of Gastroenterology 2026; 32(13): 115536 doi: 10.3748/wjg.v32.i13.115536 Abstract(54) \| Core Tip(44) \| Full Article(HTML)(288) \| Full Article with Cover (PDF)-3268K(261) \| Audio-372K(7) \| Peer-Review Report-247K(21) \| Answering Reviewers-166K(19) \| Full Article (PDF)-2585K(51) \| Full Article (XML)-336K(20) \| Times Cited (0) \| Total Visits (1032) \| Open
10	Juan Du, Kaiyi Zhang, Jiakun Miao, Yu Yang, Yuying Tian, Tianwen Wu, Cong Tao, Yanfang Wang, Shulin Yang. Molecular pathological characteristics and mechanisms of the liver in metabolic disease-susceptible transgenic pigs. Life Sciences 2025; 362: 123337 doi: 10.1016/j.lfs.2024.123337
11	Hua-Jun Feng, Sai Liang, Ding-Ting Wang, Sheng-En Xu, Gang Qin. Construction of a prognostic model for nasopharyngeal carcinoma based on serum exosomal circular RNAs and analysis of immune microenvironment. Clinical and Experimental Medicine 2025; 25(1) doi: 10.1007/s10238-025-01920-8

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.